The Physical and Emotional Effect of Vulvar Pain
NEW YORK, Aug. 28, 2012 /PRNewswire/ -- According to a study conducted by the University of Michigan, one in four women experience vulvar pain at some point in their lifetime.I Like all medical concerns, vulvar pain causes both physical and mental stress. Additionally, vulvar pain can have an adverse effect on intimacy and relationships.
Vulvar pain can be associated with menopause, breast cancer medications, or vulvar conditions such as vulvodynia, and may make sexual activity difficult to impossible. This often causes women to avoid all types of sexual activity, making their partners feel unwanted and neglected.
It typically takes women five years and at least three doctor's visits before a diagnosis is made. Since there is no cure or standard treatment option, even when a diagnosis is made it may take years to find relief. Frustration and stress are commonplace for women in this situation, resulting in low self-esteem and intimacy issues. The inability to engage in sexual intercourse not only puts a strain on the relationship, but also creates additional concern for couples that are trying to start a family.
Although there is little that can be done to ease the emotional toll of vulvar pain, there are some solutions to help with the physical discomfort. NeoGyn Vulvar Soothing Cream, a cosmetic cream formulated with Cutaneous Lysate, helps to soothe irritation and restore delicate vulvar skin, allowing women to manage their pain while they find a cure.
Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and relieve vulvar discomfort. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of propylene glycol, color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.
I. Reed, Barbara. "Prevalence and Demographic Characteristics of Vulvodynia in a Population-based Sample." American Journal of Obstetrics and Gynecology 206.2 (2012): 170.e1-170.e9.